SKIN insider buying
Beauty Health Co
Every qualifying open-market purchase of SKIN reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in SKIN yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in SKIN
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 12, 2024 | Director, Chairman | 40,450 | $1.08 | $43.7K | SEC ↗ |
SKIN insider buying — FAQ
- Are insiders buying SKIN stock?
- 1 insider has bought SKIN (Beauty Health Co) on the open market, most recently on Aug 13, 2024. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much SKIN stock have insiders bought?
- Insiders have bought a combined $43.7K of SKIN across 1 open-market purchase, based on SEC Form 4 filings.
- What is an insider cluster buy in SKIN?
- A cluster buy is two or more distinct Beauty Health Co insiders — officers, directors, or 10% owners — each buying SKIN on the open market within a rolling window. None has been detected in SKIN yet.
- Where does this SKIN insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in SKIN
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy SKIN within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding SKIN.